They have an impressive pipeline.
But it's a pharma play. A time suck
They are in phase 3 for their first drug. Once they get those results they will submit to the FDA for approval. Be a share holder before that.
I think if you see volume off the chart, buy.
Insiders and family are loading
The 3 drugs alone could be a 5+ year stretch befor all are approved.
And who knows if the entire Company is bought out for $Billions?
No one can put a date on anything. Even when the FDA gives their PUDFA date, it's not a given. God only knows what the FDA review will pop up with.
Your not going to see $50+ till approval or a buy out.
If all three become block buster treatments, this might be $200+
I wish I had a spare $10k to risk in here.
News 
Market Data 
Discover 
